Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 0.73 is in line with its 5-year average of 0.72, around the middle of its 5-year range (0.37–1.24).
As of the fiscal period ended Tuesday, June 30, 2026. 10.33% above its 12-month average of 0.66.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.73.
CURRENT RATIO
0.73
CURRENT RATIO AVG TTM
0.66
CURRENT RATIO AVG 3Y
0.71
CURRENT RATIO AVG 5Y
0.72
CURRENT RATIO AVG 10Y
0.77
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+10.33%
CURRENT VS 3Y AVG
+2.90%
CURRENT VS 5Y AVG
+1.62%
CURRENT VS 10Y AVG
-4.77%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
1.54
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
-52.49%
vs the sector median at left
Market Cap
$18.72B
Current Ratio
1.69
TTM Avg
1.94
3Y Avg
1.85
5Y Avg
1.80
Market Cap
$21.16B
Current Ratio
5.73
TTM Avg
5.92
3Y Avg
6.53
5Y Avg
6.74
Market Cap
$13.17B
Current Ratio
1.35
TTM Avg
1.35
3Y Avg
1.39
5Y Avg
1.37
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | $17.21B | 0.73 | 0.66 | 0.71 | 0.72 |
| Revvity, Inc. (RVTY)vs › | $16.26B | 1.80 | 2.64 | 2.37 | 2.14 |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $18.72B | 1.69 | 1.94 | 1.85 | 1.80 |
| Solventum Corporation (SOLV)vs › | $15.38B | 1.02 | 1.21 | 1.40 | 1.43 |
| Viatris Inc. (VTRS)vs › | $19.82B | 1.58 | 1.48 | 1.55 | 1.42 |
| Exelixis, Inc. (EXEL)vs › | $14.27B | 3.46 | 3.59 | 3.51 | 4.19 |
| STERIS plc (STE)vs › | $20.46B | 1.91 | 2.02 | 2.37 | 2.27 |
| United Therapeutics Corporation (UTHR)vs › | $21.16B | 5.73 | 5.92 | 6.53 | 6.74 |
| Charles River Laboratories International, Inc. (CRL)vs › | $13.17B | 1.35 | 1.35 | 1.39 | 1.37 |
| Penumbra, Inc. (PEN)vs › | $12.54B | 5.75 | 6.32 | 5.98 | 5.88 |
Current Ratio
0.73
Quick Ratio
0.73
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 0.73 |
| 2026-03-31 | 0.85 |
| 2025-12-31 | 0.74 |
| 2025-09-30 | 0.57 |
| 2025-06-30 | 0.43 |
| 2025-03-31 | 0.73 |
| 2024-12-31 | 0.93 |
| 2024-09-30 | 0.99 |
| 2024-06-30 | 0.88 |
| 2024-03-31 | 0.78 |
| 2023-12-31 | 0.64 |
| 2023-09-30 | 0.53 |
| 2023-06-30 | 0.44 |
| 2023-03-31 | 0.42 |
| 2022-12-31 | 0.42 |
| 2022-09-30 | 0.41 |
| 2022-06-30 | 0.37 |
| 2022-03-31 | 0.61 |
| 2021-12-31 | 1.24 |
| 2021-09-30 | 1.24 |
| 2021-06-30 | 1.16 |
| 2021-03-31 | 1.19 |
| 2020-12-31 | 1.08 |
| 2020-09-30 | 1.10 |
| 2020-06-30 | 0.94 |
| 2020-03-31 | 0.89 |
| 2019-12-31 | 0.92 |
| 2019-09-30 | 0.80 |
| 2019-06-30 | 0.66 |
| 2019-03-31 | 0.69 |
| 2018-12-31 | 0.69 |
| 2018-09-30 | 0.66 |
| 2018-06-30 | 0.68 |
| 2018-03-31 | 0.66 |
| 2017-12-31 | 0.67 |
| 2017-09-30 | 0.68 |
| 2017-06-30 | 0.79 |
| 2017-03-31 | 0.86 |
| 2016-12-31 | 0.79 |
| 2016-09-30 | 0.77 |
| 2016-06-30 | 0.85 |
| 2016-03-31 | 0.83 |
| 2015-12-31 | 0.71 |
| 2015-09-30 | 0.00 |
| 2015-06-30 | 0.00 |
| 2015-03-31 | 0.00 |
| 2014-03-31 | 0.00 |
